Share of U.S. adults who felt MMR vaccine benefits outweigh risks 2016, by age
This survey shows the percentage of U.S. adults who felt the benefits of the measles, mumps and rubella (MMR) vaccine outweigh the risks as of June 2016, by age. It was found that while around 91 percent of those aged 30-49 years felt the benefits of the MMR vaccine outweighed the risks, only 79 percent of those aged 18 to 29 felt so.